Skip to main content
. Author manuscript; available in PMC: 2014 Sep 16.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2

Comparison 2. ZIPRASIDONE versus CLOZAPINE.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Leaving the study early 1 146 Risk Ratio (M-H, Random, 95% CI) 1.0 [0.66, 1.51]
  1.1 Any reason 1 146 Risk Ratio (M-H, Random, 95% CI) 1.0 [0.66, 1.51]
2 Mental state: general mental state: PANSS total score (high=poor) 1 146 Mean Difference (IV, Random, 95% CI) −0.5 [−7.72, 6.72]
  2.1 Medium term 1 146 Mean Difference (IV, Random, 95% CI) −0.5 [−7.72, 6.72]
3 Adverse effects: cardiac effects - QTc prolongation 1 146 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]